JPRN-UMIN000016175尚未招募未知
Sarcopenia following maximal androgen suppression in men with prostate cancer - Sarcopenia following maximal androgen suppression in men with prostate cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1.prostate cancer patient without any metastasis 2. Patient with a severe renal or liver function disorder 3. Patient with double cancer
研究者
相似试验
已完成
不适用
Impact of sex hormones on sarcopenia and osteoporosis in geriatric patientsDRKS00033258Medizinische Klinik und Poliklinik IV LM590
进行中（未招募）
不适用
Sospension of androgen hormonal deprivation in patients with high levels of CgA - CgACancer histologic diagnosis of prostatic carcinoma in hormonal escapeMedDRA version: 9.1Level: HLTClassification code 10018187Term: Genitourinary neoplasms malignancy and gender unspecifiedEUCTR2009-011257-40-ITAZIENDA OSPEDALIERA S. LUIGI GONZAGA
招募中
不适用
Hormonal, bone mass and lean muscle evaluation in patients after high-dose chemotherapy for autologous hematopoietic stem cell transplantation for LymphomaRBR-4xtk65gChristianne Leal
已完成
不适用
A study on sarcopenia induced by anti-cancer molecular targeted agentsmalignancies indicated for molecular targeted agentsJPRN-UMIN000019477Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital29
进行中（未招募）
1 期
The effect of androgen deprivation therapy on the expression of prostate specific membrane antigeMedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10071119 Term: Hormone-dependent prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Metastatic prostate cancerEUCTR2018-004853-26-FITurku University Hospital35